Cargando…
Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness
Emerging evidence confirms that dyspnoea and inspiratory muscle weakness persist for up to 6 months following mechanical ventilation with #COVID19 pneumonia. Screening for inspiratory muscle weakness should be prioritised, as it may be treatable. https://bit.ly/3CBQXO2
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841315/ https://www.ncbi.nlm.nih.gov/pubmed/36687360 http://dx.doi.org/10.1183/23120541.00521-2022 |
_version_ | 1784869812229373952 |
---|---|
author | Bissett, Bernie |
author_facet | Bissett, Bernie |
author_sort | Bissett, Bernie |
collection | PubMed |
description | Emerging evidence confirms that dyspnoea and inspiratory muscle weakness persist for up to 6 months following mechanical ventilation with #COVID19 pneumonia. Screening for inspiratory muscle weakness should be prioritised, as it may be treatable. https://bit.ly/3CBQXO2 |
format | Online Article Text |
id | pubmed-9841315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-98413152023-01-19 Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness Bissett, Bernie ERJ Open Res Editorials Emerging evidence confirms that dyspnoea and inspiratory muscle weakness persist for up to 6 months following mechanical ventilation with #COVID19 pneumonia. Screening for inspiratory muscle weakness should be prioritised, as it may be treatable. https://bit.ly/3CBQXO2 European Respiratory Society 2023-01-16 /pmc/articles/PMC9841315/ /pubmed/36687360 http://dx.doi.org/10.1183/23120541.00521-2022 Text en Copyright ©The authors 2023 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Editorials Bissett, Bernie Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness |
title | Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness |
title_full | Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness |
title_fullStr | Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness |
title_full_unstemmed | Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness |
title_short | Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness |
title_sort | dyspnoea in covid-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841315/ https://www.ncbi.nlm.nih.gov/pubmed/36687360 http://dx.doi.org/10.1183/23120541.00521-2022 |
work_keys_str_mv | AT bissettbernie dyspnoeaincovid19recoverybeyondtheintensivecareunitthepotentialimpactofinspiratorymuscleweakness |